Amgen Inc (AMGN)

07:18 AM

Amgen Inc. $AMGN Shares Purchased by Advisors Asset Management Inc. - MarketBeat

07:18 AM

07:14 AM

Applying chart zones and confluence areas to Amgen Inc.2025 Market Outlook & Momentum Based Trading Ideas - Newser

07:14 AM

06:58 AM

Will Amgen Inc. benefit from macro trendsJuly 2025 PreEarnings & Real-Time Price Movement Reports - Newser

06:58 AM

06:54 AM

Amundi Sells 675,059 Shares of Amgen Inc. $AMGN - MarketBeat

06:54 AM

06:22 AM

Amgen Inc. stock trend forecastGlobal Markets & Real-Time Stock Entry Alerts - Newser

06:22 AM

06:20 AM

Adage Capital Partners GP L.L.C. Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat

06:20 AM

06:06 AM

Will Amgen Inc. see short term momentumJuly 2025 Final Week & Verified Momentum Stock Watchlist - Newser

06:06 AM

05:57 AM

Amgen’s bemarituzumab loses momentum as survival edge fades - The Pharma Letter

05:57 AM

05:54 AM

FORA Capital LLC Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat

05:54 AM

05:54 AM

Amgen Inc. $AMGN Shares Acquired by Evergreen Capital Management LLC - MarketBeat

05:54 AM

05:54 AM

Canada Pension Plan Investment Board Has $160.91 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat

05:54 AM

05:54 AM

EP Wealth Advisors LLC Purchases 8,317 Shares of Amgen Inc. $AMGN - MarketBeat

05:54 AM

05:54 AM

Panagora Asset Management Inc. Has $32.69 Million Stake in Amgen Inc. $AMGN - MarketBeat

05:54 AM

05:54 AM

Baird Financial Group Inc. Sells 26,571 Shares of Amgen Inc. $AMGN - MarketBeat

05:54 AM

03:56 AM

Jump Financial LLC Has $471,000 Position in Amgen Inc. $AMGN - MarketBeat

03:56 AM

03:56 AM

Flputnam Investment Management Co. Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat

03:56 AM

03:56 AM

Royal Bank of Canada Has $1.52 Billion Position in Amgen Inc. $AMGN - MarketBeat

03:56 AM

03:01 AM

Vident Advisory LLC Cuts Holdings in Amgen Inc. $AMGN - MarketBeat

03:01 AM

02:53 AM

Stock Analysis | Amgen OutlookNeutral Technicals, Strong Fundamentals, and Mixed Analyst Ratings - AInvest

02:53 AM

01:14 AM

Has Amgen Inc. found a price floorNew Guidance & Accurate Buy Signal Notifications - Newser

01:14 AM

12:58 PM

Trend analysis for Amgen Inc. this weekForecast Cut & High Accuracy Trade Alerts - Newser

12:58 PM

Sep 04, 2025

‘Attenuated’ Survival Benefit In Bemarituzumab Trial Delays Filing Plans - insights.citeline.com

Sep 04, 2025

Sep 04, 2025

Amgen plans $600M R&D facility at Thousand Oaks HQ - The Real Deal

Sep 04, 2025

Sep 04, 2025

AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE - MarketScreener

Sep 04, 2025

Sep 04, 2025

Global Biotech Leader Amgen to Share Business Updates at Morgan Stanley Healthcare Conference 2025 - Stock Titan

Sep 04, 2025

Sep 04, 2025

Biotech company Amgen set to build $600-million research center in Thousand Oaks - Los Angeles Times

Sep 04, 2025

Sep 04, 2025

Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug - Benzinga

Sep 04, 2025

Sep 04, 2025

Gilead, Amgen kick off facility investments in US - pharmaphorum

Sep 04, 2025

Sep 04, 2025

Should you hold or exit Amgen Inc. nowMarket Risk Analysis & Stock Portfolio Risk Management - Newser

Sep 04, 2025

Sep 03, 2025

Amgen Stock (AMGN) Slips on $600M Research Hub News - TipRanks

Sep 03, 2025

Sep 03, 2025

Amgen's 32.26% Volume Spike to 124th Rank as Shares Drop 1.07% Pre-Key Biotech Events - AInvest

Sep 03, 2025

Sep 03, 2025

Amgen Inc. $AMGN Shares Sold by Smead Capital Management Inc. - MarketBeat

Sep 03, 2025

Sep 03, 2025

The Manufacturers Life Insurance Company Purchases 600,096 Shares of Amgen Inc. $AMGN - MarketBeat

Sep 03, 2025

Sep 03, 2025

Zacks Research Predicts Amgen's Q3 Earnings (NASDAQ:AMGN) - MarketBeat

Sep 03, 2025

Sep 03, 2025

Decoding the Genetics of Obesity - Amgen

Sep 03, 2025

Sep 03, 2025

Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 - Endpoints News

Sep 03, 2025

Sep 03, 2025

Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential - MSN

Sep 03, 2025

Sep 03, 2025

Amgen (AMGN) Unveils US$600 Million Innovation Hub Expanding R&D Efforts in California - simplywall.st

Sep 03, 2025

Sep 03, 2025

Amgen’s Strategic Focus and Portfolio Strength Justify Buy Rating Despite Bemarituzumab Challenges - TipRanks

Sep 03, 2025

Sep 03, 2025

Amgen at Wells Fargo Conference: Strategic Growth and Innovation - Investing.com

Sep 03, 2025

Sep 03, 2025

Amgen dips after trial update for Zai Lab partnered gastric cancer therapy - Seeking Alpha

Sep 03, 2025

Sep 03, 2025

Amgen Inc. $AMGN Shares Sold by First Manhattan CO. LLC. - MarketBeat

Sep 03, 2025

Sep 03, 2025

Amgen to Invest $600 Million in New Science and Innovation Center at US Headquarters - geneonline.com

Sep 03, 2025

Sep 03, 2025

GW Henssler & Associates Ltd. Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Sep 03, 2025

Sep 03, 2025

First Financial Bankshares Inc Cuts Position in Amgen Inc. $AMGN - MarketBeat

Sep 03, 2025

Sep 03, 2025

Ameriflex Group Inc. Has $2.44 Million Stake in Amgen Inc. $AMGN - MarketBeat

Sep 03, 2025